MEASUREMENT OF PERSONAL RISK BEHAVI-OR IN OCCUPATIONAL RISK STUDIES AMONG HEALTH CARE WORKERS

M. Butsashvili, G. Kamkamidze, M. Kajaia, Kenrad Edwin Nelson, W. Triner, L. A. McNutt

Research output: Contribution to journalArticle

Abstract

Risky behaviours, particularly illegal and heavily stigmatized behaviours, are difficult to measure through self-report in both high risk groups and the general population. Underreporting can result in substantially biased estimates of non-injection drug use (IDU) risk of hepatitis C virus (HCV) infection. We hypothesized that asking about the existence of social networks injection drug use may be a useful marker of IDU. A cross-sectional survey of physicians and nurses was conducted in seven hospitals in Georgia. Based on survey responses participants were categorized into three IDU risk groups: ever used injecting drugs (Self IDU), reported a friend, family member or colleague used injecting drugs (Associate IDU), or reported neither (No IDU). Testing on anti-HCV was done using third generation ELISA methods. Both unadjusted and adjusted prevalence ratios between IDU risk groups and HCV prevalence were estimated. Of the 1312 (82.2%) participants, 10 (0.8%), 75 (5.7%), and 1227 (93.5%) were categorized as Self IDU, Associate IDU and No IDU, respectively; with HCV prevalence of 20%, 9.3% and 4.6%, respectively (p=0.016). The association was due primarily to women's reports. Those who reported some IDU risk were more likely to report other personal risk behaviors (e.g., multiple sex partners) and occupational risk behaviors (e.g., frequent exposure to blood and body fluids). This study represents a start of measurement development by assessing the potential usefulness of a marker to measure of IDU. Improved measurement of stigmatized behaviors is needed for confounding adjustment to improve estimates of occupational risks of blood-borne infections.

Original languageEnglish (US)
Pages (from-to)130-137
Number of pages8
JournalGeorgian medical news
Issue number274
StatePublished - Jan 1 2018

Fingerprint

Delivery of Health Care
Injections
Pharmaceutical Preparations
Hepacivirus
Risk-Taking
Social Adjustment
Sexual Partners
Body Fluids
Virus Diseases
Population Groups
Social Support
Self Report
Cross-Sectional Studies
Enzyme-Linked Immunosorbent Assay
Nurses
Physicians
Infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Butsashvili, M., Kamkamidze, G., Kajaia, M., Nelson, K. E., Triner, W., & McNutt, L. A. (2018). MEASUREMENT OF PERSONAL RISK BEHAVI-OR IN OCCUPATIONAL RISK STUDIES AMONG HEALTH CARE WORKERS. Georgian medical news, (274), 130-137.

MEASUREMENT OF PERSONAL RISK BEHAVI-OR IN OCCUPATIONAL RISK STUDIES AMONG HEALTH CARE WORKERS. / Butsashvili, M.; Kamkamidze, G.; Kajaia, M.; Nelson, Kenrad Edwin; Triner, W.; McNutt, L. A.

In: Georgian medical news, No. 274, 01.01.2018, p. 130-137.

Research output: Contribution to journalArticle

Butsashvili, M, Kamkamidze, G, Kajaia, M, Nelson, KE, Triner, W & McNutt, LA 2018, 'MEASUREMENT OF PERSONAL RISK BEHAVI-OR IN OCCUPATIONAL RISK STUDIES AMONG HEALTH CARE WORKERS', Georgian medical news, no. 274, pp. 130-137.
Butsashvili M, Kamkamidze G, Kajaia M, Nelson KE, Triner W, McNutt LA. MEASUREMENT OF PERSONAL RISK BEHAVI-OR IN OCCUPATIONAL RISK STUDIES AMONG HEALTH CARE WORKERS. Georgian medical news. 2018 Jan 1;(274):130-137.
Butsashvili, M. ; Kamkamidze, G. ; Kajaia, M. ; Nelson, Kenrad Edwin ; Triner, W. ; McNutt, L. A. / MEASUREMENT OF PERSONAL RISK BEHAVI-OR IN OCCUPATIONAL RISK STUDIES AMONG HEALTH CARE WORKERS. In: Georgian medical news. 2018 ; No. 274. pp. 130-137.
@article{cd2de2e26814422cb086e2bf6ce89a43,
title = "MEASUREMENT OF PERSONAL RISK BEHAVI-OR IN OCCUPATIONAL RISK STUDIES AMONG HEALTH CARE WORKERS",
abstract = "Risky behaviours, particularly illegal and heavily stigmatized behaviours, are difficult to measure through self-report in both high risk groups and the general population. Underreporting can result in substantially biased estimates of non-injection drug use (IDU) risk of hepatitis C virus (HCV) infection. We hypothesized that asking about the existence of social networks injection drug use may be a useful marker of IDU. A cross-sectional survey of physicians and nurses was conducted in seven hospitals in Georgia. Based on survey responses participants were categorized into three IDU risk groups: ever used injecting drugs (Self IDU), reported a friend, family member or colleague used injecting drugs (Associate IDU), or reported neither (No IDU). Testing on anti-HCV was done using third generation ELISA methods. Both unadjusted and adjusted prevalence ratios between IDU risk groups and HCV prevalence were estimated. Of the 1312 (82.2{\%}) participants, 10 (0.8{\%}), 75 (5.7{\%}), and 1227 (93.5{\%}) were categorized as Self IDU, Associate IDU and No IDU, respectively; with HCV prevalence of 20{\%}, 9.3{\%} and 4.6{\%}, respectively (p=0.016). The association was due primarily to women's reports. Those who reported some IDU risk were more likely to report other personal risk behaviors (e.g., multiple sex partners) and occupational risk behaviors (e.g., frequent exposure to blood and body fluids). This study represents a start of measurement development by assessing the potential usefulness of a marker to measure of IDU. Improved measurement of stigmatized behaviors is needed for confounding adjustment to improve estimates of occupational risks of blood-borne infections.",
author = "M. Butsashvili and G. Kamkamidze and M. Kajaia and Nelson, {Kenrad Edwin} and W. Triner and McNutt, {L. A.}",
year = "2018",
month = "1",
day = "1",
language = "English (US)",
pages = "130--137",
journal = "Georgian medical news",
issn = "1512-0112",
publisher = "Georgian Association of Business Press",
number = "274",

}

TY - JOUR

T1 - MEASUREMENT OF PERSONAL RISK BEHAVI-OR IN OCCUPATIONAL RISK STUDIES AMONG HEALTH CARE WORKERS

AU - Butsashvili, M.

AU - Kamkamidze, G.

AU - Kajaia, M.

AU - Nelson, Kenrad Edwin

AU - Triner, W.

AU - McNutt, L. A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Risky behaviours, particularly illegal and heavily stigmatized behaviours, are difficult to measure through self-report in both high risk groups and the general population. Underreporting can result in substantially biased estimates of non-injection drug use (IDU) risk of hepatitis C virus (HCV) infection. We hypothesized that asking about the existence of social networks injection drug use may be a useful marker of IDU. A cross-sectional survey of physicians and nurses was conducted in seven hospitals in Georgia. Based on survey responses participants were categorized into three IDU risk groups: ever used injecting drugs (Self IDU), reported a friend, family member or colleague used injecting drugs (Associate IDU), or reported neither (No IDU). Testing on anti-HCV was done using third generation ELISA methods. Both unadjusted and adjusted prevalence ratios between IDU risk groups and HCV prevalence were estimated. Of the 1312 (82.2%) participants, 10 (0.8%), 75 (5.7%), and 1227 (93.5%) were categorized as Self IDU, Associate IDU and No IDU, respectively; with HCV prevalence of 20%, 9.3% and 4.6%, respectively (p=0.016). The association was due primarily to women's reports. Those who reported some IDU risk were more likely to report other personal risk behaviors (e.g., multiple sex partners) and occupational risk behaviors (e.g., frequent exposure to blood and body fluids). This study represents a start of measurement development by assessing the potential usefulness of a marker to measure of IDU. Improved measurement of stigmatized behaviors is needed for confounding adjustment to improve estimates of occupational risks of blood-borne infections.

AB - Risky behaviours, particularly illegal and heavily stigmatized behaviours, are difficult to measure through self-report in both high risk groups and the general population. Underreporting can result in substantially biased estimates of non-injection drug use (IDU) risk of hepatitis C virus (HCV) infection. We hypothesized that asking about the existence of social networks injection drug use may be a useful marker of IDU. A cross-sectional survey of physicians and nurses was conducted in seven hospitals in Georgia. Based on survey responses participants were categorized into three IDU risk groups: ever used injecting drugs (Self IDU), reported a friend, family member or colleague used injecting drugs (Associate IDU), or reported neither (No IDU). Testing on anti-HCV was done using third generation ELISA methods. Both unadjusted and adjusted prevalence ratios between IDU risk groups and HCV prevalence were estimated. Of the 1312 (82.2%) participants, 10 (0.8%), 75 (5.7%), and 1227 (93.5%) were categorized as Self IDU, Associate IDU and No IDU, respectively; with HCV prevalence of 20%, 9.3% and 4.6%, respectively (p=0.016). The association was due primarily to women's reports. Those who reported some IDU risk were more likely to report other personal risk behaviors (e.g., multiple sex partners) and occupational risk behaviors (e.g., frequent exposure to blood and body fluids). This study represents a start of measurement development by assessing the potential usefulness of a marker to measure of IDU. Improved measurement of stigmatized behaviors is needed for confounding adjustment to improve estimates of occupational risks of blood-borne infections.

UR - http://www.scopus.com/inward/record.url?scp=85059798327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059798327&partnerID=8YFLogxK

M3 - Article

SP - 130

EP - 137

JO - Georgian medical news

JF - Georgian medical news

SN - 1512-0112

IS - 274

ER -